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Abstract
The principal virulence determinant of Mycobacterium tuberculosis (Mtb), the ESX-1 protein secretion system, is positively
controlled at the transcriptional level by EspR. Depletion of EspR reportedly affects a small number of genes, both positively
or negatively, including a key ESX-1 component, the espACD operon. EspR is also thought to be an ESX-1 substrate. Using
EspR-specific antibodies in ChIP-Seq experiments (chromatin immunoprecipitation followed by ultra-high throughput DNA
sequencing) we show that EspR binds to at least 165 loci on the Mtb genome. Included in the EspR regulon are genes
encoding not only EspA, but also EspR itself, the ESX-2 and ESX-5 systems, a host of diverse cell wall functions, such as
production of the complex lipid PDIM (phenolthiocerol dimycocerosate) and the PE/PPE cell-surface proteins. EspR binding
sites are not restricted to promoter regions and can be clustered. This suggests that rather than functioning as a classical
regulatory protein EspR acts globally as a nucleoid-associated protein capable of long-range interactions consistent with a
recently established structural model. EspR expression was shown to be growth phase-dependent, peaking in the stationary
phase. Overexpression in Mtb strain H37Rv revealed that EspR influences target gene expression both positively or
negatively leading to growth arrest. At no stage was EspR secreted into the culture filtrate. Thus, rather than serving as a
specific activator of a virulence locus, EspR is a novel nucleoid-associated protein, with both architectural and regulatory
roles, that impacts cell wall functions and pathogenesis through multiple genes.
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Introduction
Details of the genetic control mechanisms governing the
pathogenicity of the etiological agent of human tuberculosis are
starting to emerge [1]. It has been postulated that the DNA-
binding protein EspR [2] controls the virulence of Mycobacterium
tuberculosis (Mtb) by specifically regulating expression of EspA, an
exported protein [3,4], which is required for the ESX-1 system to
function normally. There are five genetically related ESX-systems
in Mtb but functional information is scarce for all of them,
although ESX-1 is by far the most studied [5,6]. ESX-1 is widely
considered to be the principal virulence determinant of Mtb since it
secretes the EsxAB (ESAT-6 and CFP10) proteins and ESX-1
secretion-associated proteins (Esps) [7]. Although mechanistic
details are limited, some of these secreted proteins act as effector
proteins that perturb host cell activities, permeabilize the
phagosomal membrane and allow the tubercle bacillus to escape
into the cytoplasm [6,8,9].
Structural studies revealed that EspR is a homodimer with two
domains: an N-terminal DNA-binding domain with a helix-turn-
helix (hth) motif and C-terminal domain that mediates dimeriza-
tion [10,11]. Removal of 10 amino-acid residues from the C-
terminus, as in the EspRD10 protein, does not affect DNA-binding
activity but prevents dimerization and ablates activation of the
espACD locus [2,10]. A model has been proposed, based on the
results of co-crystallization with DNA and molecular dynamic
simulations, wherein EspR employs an atypical DNA-recognition
mechanism involving a dimer of dimers. Since, for sterical reasons,
only one hth from each dimer is capable of inserting into the major
groove of DNA at a given binding site, the second hth of each
dimer remains free to act at other binding sites [10]. Consequent-
ly, dimers can dimerize then multimerize and recognize distal
DNA binding sites in a cooperative manner as has been observed
by atomic force microscopy (AFM) of EspR-nucleoprotein
complexes at the espA locus, where DNA bending and bridging
resulted in loop formation [10]. This behavior is characteristic of
nucleoid-associated proteins (NAPs) rather than that of a classical
gene activator protein [12,13]. NAPs are the bacterial equivalent
of histones that organize the chromosome and act by stabilizing
long-range structures in the genome through cooperative binding
to multiple sites. This results in modulation of the accessibility of
free DNA to the transcription machinery via the state of DNA
compaction. NAPs thus function in a quite different manner to
transcriptional activators, which typically recognize a limited
number of sites in the genome and promote transcription through
direct interaction with RNA polymerase.
To test the hypothesis that EspR might be a NAP and to gain
more insight into the extent of EspR-mediated regulation in living
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performed. Unlike cDNA hybridization to micro-arrays, ChIP-Seq
generates quantitative information with single nucleotide resolu-
tion. The complete repertoire of EspR-binding sites across the
chromosome was established with the majority of the gene targets
appearing to impact cell wall function generally rather than ESX-1
expression in particular. The ChIP-Seq findings were confirmed
independently by ChIP followed by quantitative real-time PCR
(ChIP-qPCR), by gel shift and DNase I footprinting assays, as well
as by transcript analysis, and a binding motif was deduced using
bioinformatics. Finally, the expression levels of EspR and its
subcellular localization were monitored and quantified during the
growth cycle. Altogether, these data provide a genome-wide view
of EspR regulatory functions and place EspR firmly in the NAP
family.
Results
Genome-wide analysis of the EspR regulon
We investigated EspR-binding to the chromosome of Mtb strain
H37Rv during exponential growth by ChIP-Seq, chromatin
immunoprecipitation followed by ultra-high throughput DNA
sequencing [14]. Sequence reads obtained from two independent
ChIP-Seq experiments using EspR-specific antibodies were
mapped to the Mtb H37Rv genome. Based on the peak detection
criteria, we identified 165 enriched loci harboring 582 EspR-
binding peaks (Fig. 1, Table S2), that were enriched by .1.5-fold
and these were not present in ChIP-Seq datasets from control
experiments conducted without antibody or with unrelated
antibodies (data not shown). These 165 loci occurred across the
genome (Fig. 1 and Fig. 2A) and were sited both in intergenic
regions (45%) and within genes (55%) implying that EspR is not a
classical transcriptional regulator.
Diverse functions are encoded by genes where EspR bound
upstream and classification by functional category reveals over-
representation of cell wall/cell processes and the surface-exposed
PE/PPE proteins (http://tuberculist.epfl.ch/; Fig. 2B). Internal
sites were found within AT-rich genes encoding proteins belonging
to the PPE family (Fig. 1), like ppe24 (rv1753c), and some of these,
such as ppe58 (rv3426), also bind EspR at their 59-ends. Binding
sites were present within genes that are thought to have been
acquired by horizontal transfer [15] like the rv0986-rv0989c region.
A survey of the ten top scoring peaks (Table 1) highlighted the
major EspR-binding gene targets. Two of the top three sites (Fig. 1)
occurred at a locus encoding an enzyme system that produces the
complex lipids phthiocerol dimycocerosate (PDIM) and phenolic
glycolipid (PGL) [16,17]. The second highest scoring site overlaps
the translational start of rv1490, which encodes a membrane
protein of unknown function, and this was followed by three other
peaks of lower intensity, separated by ,300–400 bp, spread across
rv1490 (Fig. 1). The fourth and eighth highest scoring sites affect
two genes, pe-pgrs19 and pe-pgrs20 [18], encoding mycobacteria-
restricted PE_PGRS proteins, while the espACD locus, which is
preceded by three EspR-binding sites (Fig. 1), occurred in the fifth
position of the top ten ChIP-Seq hits (Table 1). The ninth peak is
sited in the intergenic region between lipF (rv3487c), encoding a
lipid esterase, and rv3488, whereas the last peak of the top ten
ChIP-Seq list was found at the 39-end of fadB2 (rv0468) encoding a
beta-hydroxybutyryl-CoA dehydrogenase and upstream of umaA
(rv0469) coding for a mycolic acid synthase. EspR binds to multiple
sites in the ESX-1, ESX-2 and ESX-5 loci (Fig. S2), as well as to
two sites upstream of its own gene (Fig. 3), thus implying
autogenous control. Taken together, these data suggest that EspR
may be involved in regulating cell wall function.
Consensus sequence
An EspR consensus sequence was identified in the ChIP-Seq
peaks using the MEME suite [19] and the binding motif deduced
(Fig. 2C). FIMO (Find Individual Motif Occurrences) detected 736
occurrences of this motif (p-value#0.001) distributed among 80%
of the EspR peak sequences analyzed. Of these motifs, 59% were
localized within open reading frames (ORF). The entire Mtb
genome sequence was searched for potential EspR-binding sites
using the TTTGC[TC][GA] consensus sequence and 199
putative intergenic and 827 intragenic sites were identified, of
which 163 (43 intergenic and 120 intragenic) correspond to known
ChIP-Seq peak sites. Further experimental support for the
consensus sequence is available from footprinting studies of the
espA [10] and espR promoter regions (see below), which revealed
EspR protection from DNase I digestion at sites comprising at least
one TTTGC-like motif.
Confirmation of in vivo EspR binding
To obtain independent confirmation for selected parts of the in
vivo dataset, we initially focused on the EspR-dependent espACD
operon [2]. Our previous in vitro work revealed two EspR binding
sites separated by 19 bp and located between 506 and 444 bp
upstream of espACD [10], consistent with the presence of a ChIP-
Seq peak in this region (Fig. 1). On closer inspection, two
additional major peaks of EspR-enrichment were found further
upstream of espA (centered between 2857 bp and 2695 bp and
between 21214 bp and 21113 bp, respectively). While this work
was in progress, another report of the presence of two additional
sites upstream of espACD appeared [11]. The existence of these
sites also corroborates results we obtained previously using AFM to
visualize nucleoprotein complexes of EspR and a 1360 bp espACD
promoter fragment [10]. AFM revealed loop structures stabilized
by multiple EspR dimer of dimers suggesting the presence of
several distant EspR binding sites in the espACD upstream region.
The 59-end of the espA mRNA was located 66 bp upstream of the
translation start codon using 59 RACE (Fig. S3). Consequently, the
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the ESX-1 secretion system. It has been postulated that the
DNA-binding protein EspR controls the virulence of Mtb by
specifically regulating expression of the exported EspA
protein, which is required for ESX-1 to function. Previous
structural studies indicated that EspR forms dimers
capable of multimerizing on DNA and forming loop
structures, thus bringing together otherwise distant
chromosomal regions. Such characteristics are reminiscent
of nucleoid-associated proteins (NAPs), the histone equiv-
alent in bacteria. Here we use ChIP-Seq technology to map
EspR binding sites on the Mtb chromosome in living
bacterial cells. Genome-wide analysis of EspR identified
hundreds of binding-sites, with almost equal inter- and
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genes associated with cell wall function. We validated a
subset of EspR-binding sites experimentally and identified
a consensus motif required for optimal binding affinity.
Moreover, our study reveals that EspR expression varies
with bacterial growth and that intracellular levels are not
linked to EspR secretion. These findings corroborate the
NAP nature of EspR and its dual roles, architectural and
regulatory, that impact the Mtb chromosome and patho-
genesis globally rather than the ESX-1 loci specifically.
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PLoS Pathogens | www.plospathogens.org 2 March 2012 | Volume 8 | Issue 3 | e1002621Figure 1. Genome-wide mapping of EspR binding sites. UCSC Genome Browser (http://genome.ucsc.edu) view of EspR binding across the Mtb
genome as determined by ChIP-Seq. Peak height (y-axis) indicates the sequencing read depth at each genomic position (x-axis). Inset boxes show
major EspR binding sites identified over (from left to right) the pe_pgrs19 and pe_pgrs20 genes, the rv1490 gene, the ppe24 gene, the rv2929 and
fadD26 genes from the PDIM/PGL locus and the espACD operon promoter region.
doi:10.1371/journal.ppat.1002621.g001
Figure 2. Binding of EspR to the Mtb chromosome. (A) Pie chart of EspR-binding peaks annotated relatively to the nearest gene translation
start using the ChIPpeakAnno package [38]. (B) Bar chart displaying the percentage of genes of the EspR regulon compared to the Mtb H37Rv
genome belonging to functional categories defined in the TubercuList database (http://tuberculist.epfl.ch/). (C) Most significant motif derived from
ChIP-Seq binding sequences returned by the MEME tool [19]. The height of each letter represents the relative frequency of each base at different
positions in the consensus.
doi:10.1371/journal.ppat.1002621.g002
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the promoter.
To further validate EspR-binding peaks, with varying degrees of
enrichment, we performed ChIP followed by quantitative PCR on
11 selected sites (four located within intergenic regions, three
within ORFs and three overlapping a translational start) and two
non-peak regions (within rv0888 and sigA ORF) as controls. All of
the selected EspR-binding regions exhibited enrichment compa-
rable to that observed from ChIP-Seq analysis (Fig. S4), thus
confirming that all peaks were genuine EspR-targets.
To obtain further confirmation of the in vivo EspR binding sites,
we performed electrophoretic mobility shift assays (EMSAs) using
,100 bp DNA sequences covering the top five binding sites (Fig.
S5 and Table 1) and a DNA fragment of the same size from within
the espA ORF as a negative control. EspR was shown to bind to all
five sites in a concentration dependent manner, while the negative
control fragment remained unbound at an equal protein
concentration. However, clear differences in affinity between the
fragments were visible. For example, the top-scoring fadD26 peak
bound EspR less strongly compared to the four others suggesting
that other determinants, like long-range protein-protein or
protein-DNA interactions, could contribute to the high-affinity
binding observed in vivo.
Autogenous regulation at the espR promoter
The presence of twin peaks upstream of espR (a, b in Fig. 3A) is
suggestive of autoregulation. To test this possibility, we performed
EMSA, DNase I footprinting and 59 RACE analysis of the espR
promoter region. Peaks a and b were both shown to bind EspR
using EMSA (Fig. 3B). Two regions within peak a were protected
from DNase I by EspR; region I, covering 17 bp, and region II,
55 bp-long, are situated 101 and 76 bp upstream of the espR
translational start codon, respectively (Fig. 3C and 3D). This
binding pattern is reminiscent of that described previously at the
espA promoter [10]. When incubated with the dimerization
deficient EspRD10 protein, only part of region II and none of
region I was protected (IIaD10, 14 bp and IIbD10, 12 bp, see Fig.
S6). This implies that oligomerization enables cooperative binding
between multiple EspR dimers, leading to the formation of higher-
order oligomers. The zone protected by EspRD10 contains an
inverted repeat of two consensus motifs: CAGCAAA,16.
TTTGCTC.
59 RACE analysis was employed to localize the espR promoter
using RNA extracted from Mtb H37Rv grown to mid-log phase.
The espR transcript starts with a poly-G (7) sequence 144 bp
upstream of the translational start codon. The promoter is
therefore situated in a region between peaks a and b so
simultaneous occupation by EspR of both the a and b sites might
form a repression loop. Expression data presented below indicate a
negative effect of EspR on its own transcription.
Target gene regulation on EspR binding
To confirm the prediction that binding of EspR directly affects
target gene expression, we exploited a pristinamycin-inducible
system [20,21] to overexpress espR conditionally in Mtb (strain
H37Rv::pMYespR; Fig. 4). Compared to the controls, it is
noteworthy that espR over-expression significantly decreased
growth after 24 h (Fig. 4A) while espR transcript and EspR protein
levels were found to be ,8-fold and ,3-fold higher than in the
control after 72 h, respectively (Figs. 4C and 4B). When the
relative amounts of target transcripts in untreated and pristina-
mycin IA-treated H37Rv::pMYespR cells were measured by
quantitative RT-PCR, significantly increased transcript levels were
detected for rv1490, espA, and the ABC-transporter rv0986
(Fig. 4D). Conversely, repression of lipF transcription was also
observed upon EspR overexpression, whereas transcription of
some target genes appeared unchanged (Fig. 4D). Using a
discriminatory RT-PCR assay it was possible to measure the
impact of EspR overproduction on expression of the chromosomal
copy of espR and, again, this appeared to act negatively (Fig. 4C).
The combined findings suggest that EspR is capable of both
positive and negative transcriptional regulation. Moreover, the
inability to observe direct EspR-dependent regulation at some
major EspR binding sites suggests that EspR has no or little effect
on these genes in the conditions tested or that other regulators
counter-balance the effect of increased EspR levels.
Growth phase dependent expression of EspR
It has been proposed that intracellular levels of EspR are
regulated via its secretion by the ESX-1 system and that blocking
EspR secretion results in enhanced EspR-mediated transcriptional
effects [2]. This suggested that the intracellular requirements for
EspR could change during the growth phase of Mtb since the
secretion of other ESX-1 substrates, such as EsxA (ESAT-6), is
known to occur early in the growth cycle. To determine whether
levels were constant or variable during growth and to estimate the
number of EspR molecules per cell, kinetic experiments were
performed. We monitored EspR protein levels by quantitative
Western blotting at different time points corresponding to the
Table 1. Top 10 EspR binding loci from ChIP-Seq.
Gene Position Gene description Functional category
rv2930 inside FadD26, fatty-acid-CoA synthetase, PDIM production lipid metabolism
rv1490 overlaps start Rv1490, probable membrane protein cell wall and cell processes
rv2929 overlaps start Rv2929, PDIM production conserved hypotheticals
rv1067c overlaps start PE_PGRS family protein, PE_PGRS19 PE/PPE
rv3616c upstream EspA, ESX-1 secretion-associated protein A cell wall and cell processes
rv1753c inside PPE family protein, PPE24 PE/PPE
rv0986 inside ATP-binding protein of ABC transporter cell wall and cell processes
rv1068c upstream PE-PGRS family protein, PE_PGRS20 PE/PPE
rv3487c upstream LipF, probable esterase/lipase lipid metabolism
rv0469 upstream UmaA, Mycolic methyltransferase A 1 lipid metabolism
doi:10.1371/journal.ppat.1002621.t001
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phases of growth. Analysis of equivalent cell numbers showed that
the intracellular concentration of EspR increases throughout the
bacterial growth cycle, ranging from ,20,000 molecules at early
log-phase (day 2) to ,100,000 molecules per cell at stationary
phase (day 5) (Fig. 5A). Peak cell concentration of EspR in
stationary phase is consistent with the growth arrest observed upon
its premature induction (Fig. 4A). To determine if this peak was
due to protein accumulation or to increased expression of the espR
gene, we performed quantitative RT-PCR on RNA samples
isolated from cells at different time points (Fig. 5B). Interestingly,
throughout the growth cycle, the levels of espR mRNA varied in a
manner inversely proportional to the amounts of EspR protein,
suggesting that EspR stably accumulates in the bacteria while
Figure 3. EspR autoregulation. (A) Pattern of EspR ChIP-Seq peaks (denominated peaks a and b) identified upstream of the espR start codon. (B)
EMSA showing concentration-dependent EspR binding of DNA fragments covering the center sequences of peaks a and b shown in (A). (C) DNase I
footprint from binding of EspR to peak a of espR. Red and black peaks represent DNA without or with 10 mM EspR, respectively. Both reactions were
partially digested with DNase I and analysed by capillary electrophoresis in a genetic analyser (Applied Biosystems 3130xl). The corresponding
nucleotide sequence is shown below. Regions I and II protected from DNase I digestion by EspR are denoted by black brackets and positions relative
to the translational start are indicated. (D) Analysis of the espR promoter. The 59 end of the transcript was determined by 59 RACE using RNA
extracted from Mtb H37Rv at mid-log phase. Translational stop of rv3848 and translational start of espR are highlighted in red with +1 corresponding
to the first base of the espR open reading frame. Transcriptional start mapped by 59 RACE is boxed and indicated by a bent arrow. 210 and 235
positions for putative sigma factor binding sites are indicated. ChIP-Seq peak sequences are highlighted in gray, EspR consensus motifs framed and
sites protected from DNase I cleavage bracketed as in (C).
doi:10.1371/journal.ppat.1002621.g003
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points.
EspR is not secreted
To determine if the low intracellular levels of EspR observed at
the early and mid-log phases of growth were due to intensive EspR
secretion, we measured intra- and extra-cellular levels of EspR
from strains Mtb H37Rv and Mtb H37RvDRD1 cultured in
Sauton’s medium to mid-log phase. Under these conditions, we
were unable to detect EspR among the culture filtrate (CF)
proteins in either case, whereas EsxA was present in the CF of Mtb
H37Rv, as expected, but not in CF from the ESX-1 mutant
H37RvDRD1 that lacks esxA among other genes (Fig. 6A).
To investigate whether EspR was exported from the cytosol but
retained in the cell envelope, whole cell lysate (CL) was
fractionated by ultracentrifugation into the cell wall/cell mem-
brane (W/M) and cytosolic (CYT) components. Since the
chromosome is known to be attached to the plasma membrane
[22], half of the samples were treated with DNase I. EspR was
detected in both of the untreated fractions but was mainly in the
cytosol after DNase I treatment (Fig. 6B). Since previous studies
were performed with the Erdman strain of Mtb, this provided a
possible explanation for the localization discrepancy. Consequent-
ly, we repeated the experiment with the Mtb Erdman strain and
the ESX-1 mutant Mtb Erdman 36–72 that fails to secrete EsxA
[23]. Again, EspR was below the level of detection in the CF of
either strain, whereas EsxA appeared in the CF of Mtb Erdman
(Fig. S7). We then examined CF at different time points of Erdman
cultures for the presence of EspR and the cytosolic marker
GroEL2. EspR first appeared in the culture filtrate after 8 days of
growth when it was accompanied by GroEL2, indicating that cell
lysis had likely occurred (Fig. 6C).
Discussion
The EspR protein has attracted considerable interest because of
its role in the regulation of virulence in Mtb and the remarkable,
Figure 4. Gene expression associated with EspR binding. (A) Growth of H37Rv::pMYespR without (2P) or with (+P) pristinamycin IA. Growth
was monitored at the designated time points measuring OD600.( B) Immunoblot analysis of EspR expression in the absence (2P) or presence (+P) of
pristinamycin IA after 3 days growth using rat polyclonal antibodies specific for EspR. Equivalent amounts of total protein lysates were loaded. (C, D)
Quantitative RT-PCR analysis of relative mRNA levels extracted from H37Rv::pMYespR cells treated with 0 mg/ml or 2 mg/ml of pristinamycin using
primers specific for the following regions: (C) the espR coding region (annealing to both endogenous and vector copies of espR) or to the 59-UTR
region of espR (PespR) (specific to endogenous espR). (D) The coding regions of genes related to the top 10 EspR binding peaks as obtained in ChIP-
Seq experiments (see Table 1). Relative gene expression was normalized against sigA and displayed as fold-induction (log-2 scale) relative to the
untreated sample (0 mg/ml pristinamycin). Shown are the mean 6 s.d. of a minimum of duplicate measurements from the average of three
independent experiments. Statistical significance was evaluated using Students T-test. * indicates P,0.05, ** P,0.01 and *** P,0.001.
doi:10.1371/journal.ppat.1002621.g004
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system ESX-1 whose expression it controls [2]. This has led to the
suggestion that a negative feedback loop modulates EspR secretion
and is critical to successful infection. Studies of the three-
dimensional structure of EspR and its truncated variant,
EspRD10, together with models of DNA recognition and AFM
analysis of single molecule EspR nucleoprotein complexes,
indicate that EspR employs an atypical DNA recognition
mechanism [10,11]. A dimer of dimers is thought to bind to
DNA via one monomer of each dimer leaving the second
monomer free to contact another site. Cooperative interactions
then lead to multimerization and the formation of looped
structures in which EspR acts as a bridge between two separated,
or even remote, sites on DNA [10,11]. Such structures are
typically formed by nucleoid-associated proteins (NAPs), like H-
NS and Fis [12,24,25]. Collectively, these features led us to
consider the possibility that EspR functions as a NAP rather than
as a specific transcriptional activator of a limited number of genes
required for pathogenesis.
To test this possibility, ChIP-Seq analysis was performed to
assess the genome-wide distribution of EspR and to identify the
sites and genes to which it binds. This resulted in the identification
of at least 165 loci, often containing multiple peaks of EspR-
binding, throughout the genome. Binding sites were distributed
more or less evenly between intragenic and intergenic regions. The
majority of the genes (,50%) were involved in cell envelope
functions. Among them were genes that contribute to ESX-1,
ESX-2 and ESX-5-related activities, and others that contribute to
mycobacterial virulence, such as lipF and the PDIM locus.
Surprisingly, the latter harbored the major peak of EspR binding
in the genome whereas the previously reported site preceding the
espACD operon was less prominent (Fig. 1 and Table 1).
Confirmation of EspR binding to a selection of major sites was
obtained in vitro, from a combination of studies performed with
highly purified EspR (Fig. 3), and in vivo, following overexpression
of the protein (Fig. 4). This resulted in the definition of a consensus
sequence, TTTGC[TC][GA], that agrees well with the motif
predicted previously by molecular dynamic simulations, involving
computation of the binding energy of the optimal interaction of
EspR with the intergenic region upstream of espA [10]. These
predictions were consistent with the findings of DNase footprinting
or EMSA studies of the same locus. Using an in silico approach to
scan the genome sequence .1,000 potential EspR sites were
found, of which 163 had been detected experimentally by ChIP-
Seq. While some of the in silico predictions may be fortuitous, this
does raise the possibility that occupancy of EspR-binding sites may
vary with growth phase or physiological conditions and that more
sites will be uncovered. Furthermore, the EspR-binding motif
deduced here should be considered as a core sequence for high
affinity nucleation sites from where cooperative binding between
EspR dimers can initiate and extend to form long oligomers and
hence reach more distant sites [10]. The number of such sites and
the distance between them most probably enables EspR to
structure the chromosome.
The number of EspR molecules per cell was estimated by
quantitative Western blotting at different stages of the growth
cycle. There was a steady increase in concentration until
,100,000 molecules/cell were found at day 5. These levels are
about 30-fold higher than those of well-characterized transcrip-
tional activators, like Fnr in E. coli, but are comparable to levels of
major NAPs, such as Fis or HU, during the exponential growth
phase of E. coli [13,26]. The intracellular EspR concentration is
clearly in excess of that required to occupy all the experimentally
detected (582) or computer predicted (1026) binding sites.
Figure 5. Growth phase-dependent variation of EspR intracel-
lular levels. Time course analysis of Mtb H37Rv at the following phases
of growth: early log (day 2), mid-log (day 3) and stationary (days 4 and
5). (A) Immunoblot analysis of cell lysates (CL) from equivalent amount
of cells (approx. 2*10‘7). For quantification purposes, the indicated
amounts of purified EspR were electroblotted onto the same
membrane as cell lysates. GroEL2 is used as a loading control and
corresponding Western blot signals are used to normalize small loading
discrepancies. The number of EspR molecules per cell was estimated
from Western blot analysis correlated to OD600 measurements,
assuming that OD600 0.2=10
8 cells [40]. The results are plotted in the
bottom chart, with solid circles representing optical density at 600 nm
(OD600) while open squares represent the total number of EspR
molecules per cell from one representative of four experiments. (B)
Relative espR transcript amounts measured in total RNA harvested at
the different time points by quantitative RT-PCR and normalized to sigA
expression. The means and standard deviations of triplicate measure-
ments are shown from two experiments.
doi:10.1371/journal.ppat.1002621.g005
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mid-log phase indicate that EspR is predominantly a cytosolic
protein although it can be found attached to cell membrane-bound
DNA, a trait of the nucleoid. Prior treatment of this fraction with
DNase I releases most of the EspR to the cytosol (Fig. 6B). In
contrast to the findings of a previous report [2], we were unable to
detect the secreted form of EspR in the culture filtrates of ESX-1
proficient and deficient strains of H37Rv nor in the Erdman
strains at early time points. Since EspR is a relatively abundant
protein and only found in the culture filtrate together with the
cytosolic marker GroEL2, we conclude that it is released via cell
lysis rather than secretion mediated by ESX-1.
EspR seemingly acts as an activator or a repressor depending on
its binding position relative to the genes it controls. EspR
production appears to be autoregulated as the protein binds to
its own promoter region and downregulates expression in certain
conditions (Fig. 4C). Interaction at the espR regulatory site occurs
in a contrasting manner to that seen at the espACD locus where
there are three prominent binding sites situated far upstream of the
promoter (Fig. 1). Interestingly, some tubercle bacilli, including M.
bovis and M. microti, have incurred the RD8 deletion in this region
of the genome [27] that completely removes the three major
EspR-binding sites. Two EspR-binding sites flank the espR
promoter thus evoking an autoregulatory mechanism whereby
EspR forms a loop at the promoter that either occludes RNA
polymerase (RNAP) or traps RNAP that has already bound. In
ChIP-Seq experiments performed with RNAP-antibodies, a major
polymerase binding site was localized (data not shown) that
partially overlaps EspR peak a (Fig. 3), consistent with the
promoter prediction from 59 RACE.
Loss of EspR strongly attenuates Mtb [2], suggesting that this is
due to reduced functioning of the ESX-1 system as a result of
insufficient EspA levels. However, in light of the present findings,
this appears to be an oversimplification as expression of the genes
for several other known virulence determinants are clearly subject
to EspR regulation. Foremost among these is a major locus that
encodes an enzyme system required for synthesis of PDIM, and in
some strains PGL, both of which contribute extensively to
virulence [16,17]. Another enzyme that has an important role in
pathogenesis is the lipase, LipF [16], which has been implicated in
modification of the mycobacterial cell wall as an adaptive response
to acid damage [28]. LipF is also thought to degrade host lipids
during infection [16]. The EspR binding site (Table 1) located far
upstream of the lipF coding sequence overlaps the previously
identified 59 bp acid-inducible promoter region, situated 515 bp
from the start codon [28]. Occlusion of this site by EspR would
therefore explain the observed repression of lipF transcription
(Fig. 4D). The lipF gene, together with a number of other EspR
gene targets like fadD26 and espA, is also regulated by PhoP [29,30]
and CRP [31], frequently with opposite effects on transcription.
Regulation of transcription orchestrated by EspR seems to
occur at two levels. EspR binding at promoter regions, as in the
case of espR or lipF, resembles global transcriptional regulators
Figure 6. EspR is not a secreted protein. (A) Immunoblot analysis
of 10 mg of culture filtrate (CF) and 5 mg of cell lysates (CL) of wild-type
H37Rv (left) and H37RvDRD1 (right) strains grown for 4 days after
transfer into Sauton’s medium without Tween-80. GroEL2 was used as a
control for autolysis, SodA as a loading control for CF and CL samples
and EsxA as a control for ESX-1-dependent secretion. (B) Immunoblot
analysis of H37Rv CL shown in (A) fractionated into cell wall/cell
membrane (W/M) and cytosolic (CYT) components by ultracentrifuga-
tion. GroEL2 was used as a loading control. (C) Immunoblot analysis of
Erdman CF (20 mg) for each of the time points indicated.
doi:10.1371/journal.ppat.1002621.g006
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whereas activation of transcription occurs via favorable interaction
with RNAP and/or other proteins. On the other hand, our
genome-wide analysis revealed that more than half of the EspR-
binding sites are intragenic and this refutes, at least partially, the
hypothesis that EspR acts as a transcription factor per se. Moreover,
EspR overexpression had little effect on some major EspR-bound
genes (Fig. 4D), suggesting that EspR-binding does not necessarily
affect transcription locally but rather serves as anchoring points to
organize chromosome domains. NAPs with DNA-bridging
activity, such as EspR, are often located at the boundaries of
chromosomal domain loops [13] where they control gene
expression in a temporal or spatial manner. In many bacteria,
NAP expression levels are dependent on the growth phase [24].
This is true of Mtb since low EspR levels were detected at early-
and mid-log phase compared to stationary phase, and premature
conditional overexpression causes growth to slow down. The
interplay between different NAPs alters chromosome structure and
organization thereby influencing patterns of gene expression in a
temporal manner.
Lsr2 is a DNA-bridging protein that also performs NAP
functions in Mtb by recognizing AT-rich and xenogeneic regions.
Binding sites of Lsr2 in Mtb have been mapped by Gordon et al.
using ChIP-on-chip technology [32]. Comparison of the Lsr2
ChIP-on-chip and EspR ChIP-Seq results showed that 77% of the
genes in the EspR regulon are also likely recognized by Lsr2 [32]
owing to an extensive overlap between their repertoires (Fig. S2).
For example, all three genes significantly upregulated upon EspR
overexpression (Fig. 4D) also bind Lsr2 and major ChIP-Seq peaks
of EspR are located close to Lsr2 binding sites in the ChIP-on-chip
enriched regions (Fig. S2).
While Lsr2 and EspR are both subject to autoregulation there is
no evidence for cross-regulation and Lsr2 seems to impact many
more regions. Lsr2 has an N-terminal dimerization domain and a
C-terminal DNA-binding domain whereas in EspR the opposite
configuration exists. A further difference lies in the DNA
recognition mechanisms since Lsr2 interacts with the minor
groove while EspR binding is predicted to occur via the major
groove. Together, this suggests that EspR and Lsr2 may control
gene expression, including that of many cell wall functions, in a
divergent manner with EspR possibly replacing Lsr2 at certain
sites and vice-versa. It is striking that in all sequenced
mycobacterial genomes espR is very close to the hns gene encoding
another NAP [33] and this may also indicate functional interplay.
These hypotheses can be tested experimentally by using the
corresponding antibodies to perform ChIP-Seq experiments on
Mtb strains at different stages in the growth cycle to localize their
binding sites. The contribution of other global regulators that
intersect with the EspR regulon, like PhoP and CRP, should also
be examined. A regulatory scheme is emerging in which growth of
Mtb, and hence pathogenesis, is controlled by chromosome
remodeling, effected by different NAPs, thereby resulting in
pleiotropic regulation of gene expression. EspR may thus play a
central role in regulating virulence gene expression analagous to
that of H-NS in enteropathogenic bacteria [12,13].
Materials and Methods
Bacterial strains and culture conditions
Mycobacterium tuberculosis (Mtb) H37Rv and Erdman were grown
in 7H9 Broth (Difco) supplemented with 0.2% glycerol, Mid-
dlebrook albumin-dextrose-catalase (ADC) enrichment and 0.05%
Tween 80 or on solid Middlebrook 7H11 medium (Difco)
supplemented with oleic acid-albumin-dextrose-catalase (OADC).
Mtb cells prepared for secretion analysis and cell fractionation were
grown in Sauton liquid medium. Escherichia coli BL21(DE3) was
used for expression of His9-tagged EspR as described [10].
ChIP-Seq
Chromatin immunoprecipitation was performed essentially as
previously described [34] but with some variations. Briefly, Mtb
H37Rv cultures (50 ml) grown to OD600 0.4–0.6 were treated with
formaldehyde (final concentration 1%) for 10 min at 37uC. Cross-
linking was quenched by addition of glycine to a final
concentration of 125 mM. Harvested cells were washed twice
with Tris-buffered saline (20 mM Tris-HCl pH 7.5, 150 mM
NaCl), re-suspended in 600 ml Immunoprecipitation (IP) buffer
(50 mM Hepes-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, mini-
protease inhibitor cocktail (Roche)) and sonicated to shear DNA to
an average size of 100–500 bp. Insoluble cellular debris was
removed by centrifugation and the supernatant used as input
sample in IP experiments. 300 ml of input was incubated with
either no antibody (mock-IP) or 20 ml of serum containing rat anti-
EspR polyclonal antibodies (kindly generated by Ida Rosenkrands)
and then with 50 ml of Dynabeads sheep anti-rat IgG (Dynal
Biotech) pre-saturated with 0.1 mg/ml salmon sperm DNA and
1 mg/ml Bovine Serum Albumin (BSA) in IP buffer. Washing and
crosslink reversal of protein-DNA complexes, as well as purifica-
tion of the resulting DNA was carried out as previously described
[34]. Prior to sequencing, DNA fragment sizes were checked and
enrichment was verified by gene-specific quantitative PCR (ChIP-
qPCR).
EspR ChIP-Seq library construction and sequencing
DNA fragments (150 to 250 bp) were selected for library
construction and sequencing libraries prepared using the ChIP-
Seq Sample Preparation Kit (Illumina; San Diego, California,
USA; Cat. No. IP-102-1001) according to the protocol supplied
with the reagents. Prior and post library construction, chromatin
immunoprecipitation products were quantified using the Qubit
fluorometer (Invitrogen; Carlsbad, California, USA). One lane of
each library was sequenced on the Illumina Genome Analyzer IIx
using the Single-Read Cluster Generation Kit v4 and 36 Cycle
Sequencing Kit v4. Data were processed using the Illumina
Pipeline Software v1.60.
ChIP-Seq data analysis
ChIP-Seq experiments, with two independent mid-log phase
cultures, generated 25.6 and 22 million reads, of which 95% could
be successfully mapped to the Mtb H37Rv genome (NCBI
accession NC_000962.2) using Bowtie [35] allowing up to 3
mismatches and up to 10 hits per read. As a control, input DNA
was also sequenced and mapped to the Mtb H37Rv genome to
identify sequencing artifacts and calculate enrichment values.
Since comparison of the two ChIP-Seq datasets showed excellent
correlation in binding signals (Fig. S1), sequenced DNA reads from
both experiments were pooled together. In order to estimate the
binding location in the enriched regions, we used a deconvolution
algorithm that models the expected tag distribution on both
strands [36]. Based on the deconvoluted profile, a score was
calculated for each peak that was proportional to the read density
in the peak. Considering the high genome coverage, only peaks
with more than 600 reads per position were selected. Reads
mapped to the forward and reverse strands were shifted (by 80 bp)
and merged together to generate single peak profiles, which were
visualized on the UCSC Genome Browser database [37].
Annotation of the peaks was performed using the ChipPeakAnno
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region (400 bp width) was determined as the total number of reads
mapping to the region divided by the length of the region
normalized to the total number of mapped reads across the whole
genome. The enrichment at each locus was obtained as the ratio of
the average read count from the ChIP sample (from two datasets)
to the read count from the input DNA sample. Peaks with an
enrichment ratio lower than 1.5 were filtered out. The ChIP-Seq
data files have been deposited in NCBI’s Gene Expression
Omnibus [39] and can be accessed through GEO Series accession
number GSE35149. Lsr2 data were retrieved from this database
(accession number GSE18652).
Motif detection
Sequences of 102 bp covering the center of the 582 peaks that
fulfilled the peak selection criteria were extracted and used for
motif analysis using MEME [19] with motif occurrence set as
‘‘zero or one per sequence’’, minimum width as 5 and other
parameters as default. Since many EspR binding sites are found
within the highly repetitive sequences belonging to pe and ppe
genes, the initial motif returned by MEME was biased and
reflected a pe-ppe motif. Thus, from the 582 sequences, those
belonging to the pe and ppe categories were excluded, leaving 416
sequences that were reanalyzed using MEME. This led to the
identification of an unbiased overrepresented motif shown in Fig. 2.
This motif was further used in FIMO (Find Individual Motif
Occurences) from the MEME Suite web server [19] to search for
motif occurrence in the entire set of EspR binding sequences
setting the p-value threshold to 0.001.
Electrophoretic mobility shift assays (EMSA) and DNase I
footprinting
EspR protein was produced and purified as previously described
[10] and used in EMSA, DNase I footprinting and quantitative
Western Blot experiments, as well as to immunize rats. EspR-DNA
gel retardation assays were performed as recently described [10]
using 59-biotin-labeled forward primers and unlabeled reverse
primers in PCR reactions designed to yield DNA probes of 99 to
120 bp encompassing selected ChIP-Seq peak sequences for
analysis. DNase I footprinting assay was carried out using 6-
FAM-labeled probes as described in [10]. 6-FAM-labeled forward
primers and unlabeled reverse primers were used to synthesize a
361 bp DNA fragment starting 208 bp upstream of the espR
translational start by PCR. The nucleotide sequences of protected
regions were determined by DNA sequencing.
59 RACE
RNA was extracted from Mtb H37Rv cells in the mid-log phase.
59 RACE was performed as previously described [34] using the
59/39 RACE kit (2nd Generation, Roche) and primers specific for
espA and espR for 59-end mapping (see Table S1).
Inducible overexpression of EspR in Mtb H37Rv
Construction of the pMYespR vector for pristinamycin IA-
inducible overexpression of espR was undertaken as previously
described [21]. Plasmids pMYespR and the control pMY769 were
transformed into H37Rv strain by electroporation, clones were
selected on 7H11 agar plates containing 100 mg/ml spectinomycin
and plasmid integration verified by PCR. The resulting
H37Rv::pMYEspR strain was grown to mid-log phase (OD600
0.4–0.6), diluted to OD600=0.1 (day 0) and split into two 30 ml
volumes prior to addition of 0 or 2 mg/ml pristinamycin IA. Cells
were harvested at day 3.
For whole cell Western blot analysis, bacteria were pelleted,
washed twice in PBS containing 0.05% Tween 80 and
resuspended in lysis buffer (10 mM Tris pH 7.9, 500 mM NaCl,
1m Mb-mercaptoethanol, 5% glycerol, 0.1 mM EDTA) prior to
sonication (15 min at 4uC). Cell debris was then pelleted and the
supernatant filter sterilized. After total protein quantification using
Bradford reagent (Sigma), 10 mg of cell lysates were separated by
SDS-PAGE, and specific proteins visualized by immunoblot as
described below.
Immunoblot analysis
Proteins were separated on NuPAGE Novex 4–12% bis-Tris
gels (Invitrogen) and transferred to nitrocellulose membranes.
Membranes were incubated in TNT blocking buffer (25 mM Tris
pH 7.5, 150 mM NaCl, 0.05% Tween 20) with 5% w/v skim milk
powder for 2 h prior to incubation with primary antibodies diluted
in TNT with 1% BSA overnight. Membranes were washed in
TNT five times, then incubated with secondary antibodies for 1 h
before washing. Immunoblotting were performed with rat
polyclonal anti-EspR antibodies (kindly provided by Ida Rosenk-
rands), mouse monoclonal anti-EsxA antibodies (Hyb 76-8), mouse
monoclonal anti-GroEL2 antibodies (IT-70), rabbit polyclonal
anti-EsxB and anti-SodA antibodies. All antibodies were used at a
dilution 1:1,000 except for anti-GroEL2 (1:5,000), anti-EsxB
(1:500) and anti-SodA (1:50). Horseradish peroxidase (HRP)
conjugated rabbit polyclonal anti-rat IgG, rabbit polyclonal anti-
mouse IgG or goat polyclonal anti-rabbit IgG secondary
antibodies (Sigma) were used at dilutions of 1:100,000. Secondary
antibodies were visualized using chemiluminescent substrates
(Sigma).
Quantitative RT-PCR
Quantitative RT-PCR reactions were performed with the
7900HT Fast Real-Time PCR System (Applied Biosystems) with
the following parameters: 50uC for 2 min, 95uC for 10 min,
followed by 40 cycles of 95uC for 15 s and 60uC for 60 s. Melt
curve analysis was used to confirm specific amplification for each
primer pair. Threshold cycle values were determined automati-
cally using the SDS software.
Enrichment of ChIP DNA samples was measured by quanti-
tative RT-PCR using peak-specific primer pairs (Table S1), IP or
mock-IP DNA as template and SYBR-Green master mix (Applied
Biosystems). To calculate the amount of amplified DNA, standard
curves were generated for each primer pair using 10-fold dilutions
of input DNA as template. All reactions were done in duplicate
and averaged to determine the enrichment ratio calculated as [IP
DNA]/[mock-IP DNA].
For gene expression analysis, RNA was extracted with Trizol
reagent (Invitrogen) and treated with DNase I (Roche) prior to
generation of the cDNA template. cDNA was synthesized using
the RevertAid First Strand cDNA Synthesis Kit (Fermentas)
according to the manufacturer’s instructions using random
hexamers primer. cDNA corresponding to 10 ng of input RNA
was used in each RT-PCR reaction supplemented with specific
primer pairs (200 nM each) listed in Table S1 and SYBR-Green
master mix (Applied Biosystems). Relative mRNA levels were
calculated using the DDCt method, normalizing transcript levels to
sigA signals and are average of three biological replicates.
Time course expression analysis
Mtb H37Rv cells were grown to OD600 0.6 and then diluted in
100 ml with a starting OD600 of 0.05 (day 0). At various time
points corresponding to the early-log (day 2), mid-log (day 3) and
stationary (days 4 and 5) phase of growth, the number of cells was
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centrifugation for RNA and protein analysis. For protein analysis,
400 to 100 ml cell aliquots were resuspended in a 16 NuPAGE
sample buffer (Invitrogen) and boiled for 45 min. For all time
points, equivalent amounts of cells were subjected to SDS-PAGE
together with purified EspR protein standards (40, 30, 20, 15, 10
and 7.5 ng) and proteins detected by immunoblotting. Quantifi-
cation was performed by densitometry of scanned blots using the
ImageJ software. A standard curve was made from the intensity of
the purified EspR bands and was shown to be linear in the 7.5 to
40 ng range. Quantification of expression levels at each time point
was estimated from the standard curve after correction for small
sample loading discrepancies using GroEL2 band intensity for
normalization. The experiment was repeated four times and a
typical immunoblot pattern of EspR expression is shown in
Fig. 5A. For transcript analysis, RNA isolation and quantitative
RT-PCR was performed as described above.
EspR secretion analysis
Mtb starter cultures were first grown in complete 7H9 broth to
late-logarithmic phase (OD600,0.8–1). These were then used to
inoculate Sauton’s medium supplemented with 0.05% Tween-80,
at starting OD600 of 0.1. Cells were grown to mid-log phase of
growth (OD600,0.6), centrifuged, washed once with phosphate
buffered saline (PBS), resuspended in a volume of Sauton’s
medium without Tween-80 such that the OD600 was again ,0.6
then grown further at 37uC with shaking. Cultures were harvested
at required times post-transfer by centrifugation to obtain culture
filtrates and cell pellets. Culture filtrates (CF) were filtered
sequentially through 0.4 and 0.2 micron filters to remove any
residual cells and concentrated in Vivaspin columns with 5-kDa
molecular weight cut-off membranes (Sartorius Stedim Biotech
GmbH, Goettingen, Germany). Cell lysates (CL) were prepared by
resuspending cell pellets in lysis buffer (PBS containing Roche
mini-protease inhibitor cocktail tablets) followed by bead beating
with 100 micron glass beads and centrifuged. Total protein
concentration of all preparations was determined using the BCA
assays (Pierce) with BSA as the standard. Equivalent total protein
concentrations of CF and CL were analyzed by SDS-PAGE and
immunoblotting. For cell fractionation experiments, CL samples
were split into two equivalent volumes and treated with either
50 ml PBS or 50 ml of 1,000 units/ml DNase I overnight at 4uC.
CL samples were centrifuged at 200,000 g for 4 h at 4uCi na
Beckman-Coulter ultracentrifuge (TLA-100.3 rotor) to obtain the
cell wall/cell membrane (W/M) fraction. Supernatants containing
the cytosolic (CYT) fractions were carefully recovered and the W/
M fractions resuspended in PBS with 0.1% Triton X-100 and
mini-protease inhibitor cocktail. Equivalent amounts of the
different cell fractions were separated by SDS-PAGE and specific
proteins were visualized by immunoblotting.
Supporting Information
Figure S1 Correlation plot showing the reproducibility of EspR
ChIP-Seq.
(PDF)
Figure S2 Comparison of EspR and Lsr2 binding sites on the
Mtb genome. (A) Venn diagram showing significant overlap
between the gene targets of Lsr2 [32] as obtained by ChIP-on-chip
and EspR as obtained by ChIP-Seq (this study). (B–F) UCSC
Genome Browser (http://genome.ucsc.edu) view of selected
binding profiles as determined by ChIP-Seq for EspR (green, this
study) and by ChIP-on-chip for Lsr2 (red, [32]). Shown are (B) the
rv1490 region; (C) the rv0986-7-8 operon region; (D) the espA-ephA
intergenic region; (E) the ESX-1 (rv3864-3883c) and ESX-2
(rv3884c-rv3895c) regions; and (F) the PDIM/PGL locus (rv2928-
rv2962c). The GC content of Mtb H37Rv genome (in 20 bp
windows) normalized to the median GC content (65.6%) and the
gene positions are indicated below.
(PDF)
Figure S3 Analysis of the espA promoter. RNA extracted from
Mtb H37Rv at mid-log phase was used for the 59 RACE.
Translational starts are highlighted in red with +1 corresponding
to the first base of the espA open reading frame. Transcriptional
start mapped by 59 RACE is boxed and indicated by a bent arrow.
210 and 235 positions for putative sigma factor binding sites are
indicated. ChIP-Seq peak sequences are highlighted in gray.
(PDF)
Figure S4 Validation of 11 EspR-binding sites selected among a
wide range of scores by quantitative RT-PCR. The sigA and
rv0888 genes, showing no peak in EspR ChIP-Seq, were used as
negative controls. Plot showing log2 enrichment calculated from
ChIP-Seq and ChIP-qPCR experiments shows a good correlation
between the output of the two experiments. The log2 enrichment
values have also been indicated in the table below along with
additional details about the peaks. The column ‘‘Peak feature’’
indicates where the EspR-binding site is located relative to the
known gene annotation. ‘‘NA’’ denotes not applicable.
(PDF)
Figure S5 EMSA showing binding to the top five ChIP-Seq
peak sequences related to the following genes: fadD26, rv1490,
rv2929, pe_pgrs19, espA. A DNA fragment from within the espA
coding region where no ChIP-Seq enrichment was observed was
used as negative control.
(PDF)
Figure S6 DNase I footprint at peak ‘‘a’’ of the espR promoter.
Red and black peaks represent DNA incubated without or with
10 mM EspR proteins, respectively. Both reactions were partially
digested with DNase I and analysed by capillary electrophoresis in
a genetic analyser (Applied Biosystems 3130xl). The corresponding
sequencing reaction of the DNA fragment is shown at bottom.
Regions I and II protected from DNase I digestion by EspR and
regions IIaD10 and IIbD10 protected from DNase I digestion by
EspRD10 are denoted by square brackets. Positions indicated are
relative to the translational start.
(PDF)
Figure S7 Immunoblot analysis of 10 mg of culture filtrate (CF)
and 5 mg of cell lysates (CL) of Mtb Erdman wild-type (left) and
36–72 (transposon insertion in the pe35 promoter blocking esxA
expression and therefore ESX-1 function [23]) (right); strains were
grown for 4 days after transfer into Sauton’s medium without
Tween-80. GroEL2 was used as a control for autolysis, SodA as a
loading control for CF and CL samples and EsxA as a control for
ESX-1-dependent secretion.
(PDF)
Table S1 List of primers used in this study.
(PDF)
Table S2 List of the EspR ChIP-Seq peaks on the Mtb H37Rv
genome sorted by score (highest to lowest). Peaks are numbered by
order of appearance in the genome. The column ‘‘Feature’’
indicates where the EspR-binding site is located relative to the
known gene annotation. The ‘‘Distance to feature’’ column
designates the distance (in bp) from the midpoint position of the
calculated peak to the closest translational start site. Values in the
‘‘Score’’ column are arbitrary units proportional to the peak
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the average ChIP-Seq read count at a particular locus (400 bp)
and the input DNA read count at that locus.
(XLS)
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